Testing women for human immunodeficiency virus infection: Who, when, and how?

Clinical Obstetrics and Gynecology

Volumn 51, Issue 3, 2008, Pages 507-517

  Clark, J ^a,b,d   Lampe, Margaret A ^b   Jamieson, Denise J ^c  

^a NORTHROP GRUMMAN CORPORATION   (United States)

^b Viral Hepatitis STD and TB Prevention   (Georgia)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^d MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

HIV testing; Women

Indexed keywords

ZIDOVUDINE;

ARTICLE; CLINICAL TRIAL; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; GYNECOLOGY; HEALTH CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MATERNAL CARE; OBSTETRICS; PATIENT CARE; POPULATION; PREVALENCE; SCREENING; UNITED STATES; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION; ADOLESCENT; ADULT; DISEASE TRANSMISSION; FEMALE; HEALTH CARE POLICY; HUMAN IMMUNODEFICIENCY VIRUS; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; NEWBORN; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; SERODIAGNOSIS; STANDARD; WOMEN'S HEALTH;

ADOLESCENT; ADULT; AIDS SERODIAGNOSIS; DIAGNOSTIC TESTS, ROUTINE; DISEASE TRANSMISSION, VERTICAL; FEMALE; GYNECOLOGY; HEALTH POLICY; HIV; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; MASS SCREENING; OBSTETRICS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; UNITED STATES; WOMEN'S HEALTH;

EID: 54449086646     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3181809263     Document Type: Article

References (38)

1. CDC. HIV/AIDS surveillance in women (through 2005). 2007 [cited October 30, 2007]. Available at: http://www.cdc.gov/ hiv/topics/surveillance/ resources/slides/ women/index.htm.
2. CDC. Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome. MMWR Recomm Rep. 1985;34:721-722.
3. Connor EM, Sperling RS, Gelber R, etal. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180.
4. CDC. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Recomm Rep. 1995;44:1-15.
5. American Academy of Pediatrics, American College of Obstetricians and Gynecologists. Human immunodeficiency virus screening. Pediatrics. 1999;104:128.
6. CDC. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR Recomm Rep. 1999;48:1-28.
7. Glynn M, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003. National HIV Prevention Conference June 2005; Atlanta, GA.
8. CDC. Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings. MMWR Recomm Rep. 1993;42:1-6.
9. CDC. Revised guidelines for HIV counseling, testing, and referral. MMWR Recomm Rep. 2001;50:1-57.
10. Troccoli K, Pollard H, McMahon M, et al. Human immunodeficiency virus counseling and testing practices among North Carolina providers. Obstet Gynecol. 2002;100:420-427.
11. Institute of Medicine. No Time to Lose: Getting More From HIV Prevention. Washington, DC: National Academy Press; 2000.
12. Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion. 2002;42:975-979.
13. McKenna MT, Hu X. Recent trends in the incidence and morbidity that are associated with perinatal human immunodeficiency virus infection in the United States. Am J Obstet Gynecol. 2007;197 (3 suppl):S10-S16.
14. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20:1447-1450.
15. CDC. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health care settings. MMWR Recomm Rep. 2006;55: 1-17.
16. American College of Obstetricians and Gynecologists. ACOG Committee Opinion #357: primary and preventive care: periodic assessments. Obstet Gynecol. 2006;108:1615.
17. CDC. Revised recommendations for HIV screening of pregnant women. MMWR Recomm Rep. 2001;50:63-85.
18. American College of Obstetricians and Gynecologists. ACOG Committee Opinion #304: prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Obstet Gyne-col. 2004;104:1119-1124.
19. HIV Medicine Association. HIV Experts Applaud CDC Move to Make HIV Testing Routine. 2006 [cited December 5, 2007]. Available at: http://www.hivma.org/ Content.aspx?id=3860.
20. American Medical Association. Improving Access to Rapid HIV Testing: An Update. Report 2 of the Council on Science and Public Health (I-06). 2006 [cited December 5, 2007]. Available at: http://www.ama-assn.org/ama/pub/category/ 17011.html.
21. American College of Obstetricians and Gynecologists. ACOG Committee Opinion #313: the importance of preconception care in the continuum of women's health care. Obstet Gynecol. 2005;106: 665-666.
22. Johnson K, Posner SF, Biermann J, et al. Recommendations to improve preconception health and health care - United States. A report of the CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care. MMWR Recomm Rep. 2006;55:1-23.
23. Lampe MA. Human immunodeficiency virus-1 and preconception care. Matern Child Health J. 2006;10(5 suppl): S193-S195.
24. United States Public Health Service Task Force. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. November 2, 2007 [cited December 4, 2007]. Available at: http://AIDSinfo.nih.gov.
25. US Preventive Services Task Force. Screening for HIV: Recommendation statement. Agency for Healthcare Research and Quality, Rockville, MD [AHRQ Publication No. 07-0597-EF-2] July 2005 amended April 2, 2007 [cited October 30, 2007]. Available at: http:// www.ahrq.gov/clinic/uspstf05/hiv/hivrs.htm.
26. Birkhead G, Kowalski E, Hackel S, et al. The contribution of infection acquired during pregnancy to residual mother-to-child HIV transmission rates in New York State. XVI International AIDS Conference August 13-18, 2006; Toronto, Ontario.
27. Patterson KB, Leone PA, Fiscus SA, et al. Frequent detection of acute HIV infection in pregnant women. AIDS. 2007; 21:2303-2308.
28. Sansom SL, Ruffo N, Campsmith M. Incidence of maternal HIV seroconversion during pregnancy in 10 of the United States, 1999-2001. XVI International AIDS Conference. August 13-18, 2006; Toronto, Ontario.
29. Sansom SL, Jamieson DJ, Farnham PG, et al. Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission. Obstet Gynecol. 2003;102: 782-790.
30. Lampe M, Branson BM, Paul S, et al. Rapid HIV-1 antibody testing during labor and delivery for women of unknown HIV status: a practical guide and model protocol. January 30, 2004 [cited October 30, 2007]. Available at: http:// www.cdc.gov/hiv/topics/testing/resources/ guidelines/pdf/ Labor&DeliveryRapidTesting.pdf.
31. Guay L, Musoke P, Fleming T. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354: 795-802.
32. Moodley D, Moodley J, Coovadia H. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type-1. J Infect Dis. 2003; 167:725-735.
33. Wade NA, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med. 1998;339:1409-1414.
34. Bulterys M, Jamieson DJ, O'Sullivan MJ, et al. Rapid HIV-1 testing during labor: a multicenter study. JAMA. 2004;292: 219-223.
35. Jamieson D, Cohen M, Maupin R, et al. Rapid human immunodeficiency virus-1 testing on labor and delivery in 17 U.S. hospitals: the MIRIAD experience. Am J Obstet Gynecol. 2007;197(3 suppl): S72-S82.
36. Institute of Medicine. Reducing the Odds: Preventing Perinatal Transmission of HIV in the United States. Washington, DC: National Academy Press; 1999.
37. CDC. HIV Testing Among Pregnant Women - United States and Canada, 1998-2001. MMWR. 2002;51:1013-1016.
38. Gerberding JL, Jaffe HW. "Dear Colleague" letter. April 22, 2003 [cited October 30, 2007]. Available at: http:// www.cdc.gov/hiv/ projects/perinatal/2003/ letter.htm.